These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727 [TBL] [Abstract][Full Text] [Related]
5. CD26/DPP IV in experimental and clinical organ transplantation. Korom S; de Meester I; Belyaev A; Schmidbauer G; Schwemmle K Adv Exp Med Biol; 2003; 524():133-43. PubMed ID: 12675233 [TBL] [Abstract][Full Text] [Related]
6. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353 [TBL] [Abstract][Full Text] [Related]
7. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations. Ruiz P; Zacharievich N; Shenkin M Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992 [TBL] [Abstract][Full Text] [Related]
8. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain? Iwaki-Egawa S; Watanabe Y; Fujimoto Y Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235 [TBL] [Abstract][Full Text] [Related]
9. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)). Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349 [TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Hildebrandt M; Rose M; Mayr C; Arck P; Schüler C; Reutter W; Salama A; Klapp BF Adv Exp Med Biol; 2000; 477():197-204. PubMed ID: 10849747 [TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status. Ruiz P; Hao L; Zucker K; Zacharievich N; Viciana AL; Shenkin M; Miller J Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038 [TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26. Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177 [TBL] [Abstract][Full Text] [Related]
14. Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution. Detel D; Buljevic S; Pucar LB; Kucic N; Pugel EP; Varljen J J Physiol Biochem; 2016 Sep; 72(3):405-19. PubMed ID: 27125676 [TBL] [Abstract][Full Text] [Related]
15. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Varga T; Somogyi A; Barna G; Wichmann B; Nagy G; Rácz K; Selmeci L; Firneisz G Pathol Oncol Res; 2011 Dec; 17(4):925-30. PubMed ID: 21785903 [TBL] [Abstract][Full Text] [Related]
16. Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis. Yeganeh F; Mousavi SMJ; Hosseinzadeh-Sarband S; Ahmadzadeh A; Bahrami-Motlagh H; Hoseini MHM; Sattari M; Sohrabi MR; Pouriran R; Dehghan P Clin Rheumatol; 2018 Dec; 37(12):3183-3190. PubMed ID: 30136129 [TBL] [Abstract][Full Text] [Related]
17. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Hildebrandt M; Rose M; Mayr C; Schüler C; Reutter W; Salama A; Klapp BF Scand J Immunol; 1999 Nov; 50(5):536-41. PubMed ID: 10564557 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837 [TBL] [Abstract][Full Text] [Related]
19. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy. Yıldırım FE; Karaduman A; Pinar A; Aksoy Y Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066 [TBL] [Abstract][Full Text] [Related]
20. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease. Buljevic S; Detel D; Pugel EP; Varljen J J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]